Benecchi Christopher
SEC insider (Form 3/4/5 filer). CIK 0001881403. Chief Operating Officer at Sage Therapeutics, Inc. (SAGE). 9 reported Form 4/5 transactions since Sep 2024; latest on Jul 31, 2025. Located in CAMBRIDGE, MA.
Companies Benecchi Christopher has filed insider reports for
- Sage Therapeutics, Inc. (SAGE): Officer, Chief Operating Officer
Benecchi Christopher
CIK: 0001881403
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Sage Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jul 31, 2025SAGE
Sage Therapeutics, Inc.
DispositionDirect28.1K shares- - Jul 31, 2025SAGE
Sage Therapeutics, Inc.
DispositionDirect36.4K shares- - Apr 10, 2025SAGE
Sage Therapeutics, Inc.
AwardDirect2.7K shares- - Apr 10, 2025SAGE
Sage Therapeutics, Inc.
Tax PaymentDirect661 shares at avg. $6.91$5K - Apr 10, 2025SAGE
Sage Therapeutics, Inc.
AwardDirect3.3K shares- - Apr 10, 2025SAGE
Sage Therapeutics, Inc.
Tax PaymentDirect793 shares at avg. $6.91$5K - Feb 13, 2025SAGE
Sage Therapeutics, Inc.
Tax PaymentDirect822 shares at avg. $7.18$6K - Jan 16, 2025SAGE
Sage Therapeutics, Inc.
AwardDirect20K shares- - Nov 1, 2024SAGE
Sage Therapeutics, Inc.
AwardDirect6.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 31, 2025 | SAGE Sage Therapeutics, Inc. | Disposition | 28,053 | - | - | Direct |
| Jul 31, 2025 | SAGE Sage Therapeutics, Inc. | Disposition | 36,375 | - | - | Direct |
| Apr 10, 2025 | SAGE Sage Therapeutics, Inc. | Award | 2,712 | - | - | Direct |
| Apr 10, 2025 | SAGE Sage Therapeutics, Inc. | Tax Payment | 661 | $6.91 | $4,568 | Direct |
| Apr 10, 2025 | SAGE Sage Therapeutics, Inc. | Award | 3,255 | - | - | Direct |
| Apr 10, 2025 | SAGE Sage Therapeutics, Inc. | Tax Payment | 793 | $6.91 | $5,480 | Direct |
| Feb 13, 2025 | SAGE Sage Therapeutics, Inc. | Tax Payment | 822 | $7.18 | $5,902 | Direct |
| Jan 16, 2025 | SAGE Sage Therapeutics, Inc. | Award | 20,000 | - | $0 | Direct |
| Nov 1, 2024 | SAGE Sage Therapeutics, Inc. | Award | 6,250 | - | $0 | Direct |
1-9 of 9 transactions